MRVEarnings•globenewswire•
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
Sentiment:Neutral (60)
Summary
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 11, 2025 by globenewswire